These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 463884)

  • 21. Ambivalency at the bedside: intraperitoneal chemotherapy.
    Rodriguez AO
    Curr Opin Obstet Gynecol; 2007 Feb; 19(1):1-2. PubMed ID: 17218843
    [No Abstract]   [Full Text] [Related]  

  • 22. Comprehensive pharmacy services in an 85-bed hospital.
    Tanner DJ
    Am J Hosp Pharm; 1976 Apr; 33(4):340-9. PubMed ID: 817598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of concurrent monitoring and a preprinted note to modify prescribing of i.v. cimetidine and ranitidine in a teaching hospital.
    Dannenhoffer MA; Slaughter RL; Hunt SN
    Am J Hosp Pharm; 1989 Aug; 46(8):1570-5. PubMed ID: 2773962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct order entry by physicians in a computerized hospital information system.
    Schroeder CG; Pierpaoli PG
    Am J Hosp Pharm; 1986 Feb; 43(2):355-9. PubMed ID: 3953596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quality of prescription at a tertiary care pharmacy in Addis Ababa.
    Makonnen E; Yoseph M; Berhane Y
    Ethiop Med J; 2002 Jul; 40(3):233-9. PubMed ID: 12602247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Controlling admixture waste through pharmacist monitoring.
    Adachi WD; Endo AY; Tanaka JY
    Am J Hosp Pharm; 1984 May; 41(5):883. PubMed ID: 6731449
    [No Abstract]   [Full Text] [Related]  

  • 27. [Drug committees in Denmark. Status and future challenges].
    Rabøl R; Kampmann JP; Christensen HR
    Ugeskr Laeger; 2004 Aug; 166(35):2988-91. PubMed ID: 15387009
    [No Abstract]   [Full Text] [Related]  

  • 28. Recommended methods for compounding intravenous admixtures in hospitals.
    Am J Hosp Pharm; 1975 Mar; 32(3):261-70. PubMed ID: 1136973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review of the justification for pharmacy parenteral admixture preparation.
    Schneider PJ
    Hosp Pharm; 1981 Sep; 16(9):476, 478-9, 484. PubMed ID: 10252377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New revenue and improved services in handling ambulatory radiology patients.
    Blair WJ; Ortiz G
    Hosp Pharm; 1979 Oct; 14(10):608-9. PubMed ID: 10244320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intraperitoneal cisplatin therapy in ovarian cancer: comparison with standard intravenous carboplatin and paclitaxel.
    Ozols RF; Bookman MA; du Bois A; Pfisterer J; Reuss A; Young RC
    Gynecol Oncol; 2006 Oct; 103(1):1-6. PubMed ID: 16904166
    [No Abstract]   [Full Text] [Related]  

  • 32. Letter: Pharmacy attachment of intravenous sets.
    Nowak MM; Quinby GE
    Am J Hosp Pharm; 1975 Oct; 32(10):984. PubMed ID: 811117
    [No Abstract]   [Full Text] [Related]  

  • 33. Intravenous admixture services in a community hospital.
    Allen JE
    Hosp Mater Manage Q; 1986 May; 7(4):55-62. PubMed ID: 10276219
    [No Abstract]   [Full Text] [Related]  

  • 34. Reducing medication errors: safest in America targets error-prone prescribing practices.
    Thomas M
    Minn Med; 2004 Apr; 87(4):44-5. PubMed ID: 15144163
    [No Abstract]   [Full Text] [Related]  

  • 35. Uses of a Xerox 800 electronic typing system in an intravenous additive service.
    Sargalski PJ
    Hosp Pharm; 1977 Jun; 12(6):285-7. PubMed ID: 10305443
    [No Abstract]   [Full Text] [Related]  

  • 36. Indicators to control drug costs in hospitals.
    Mehl B
    Am J Hosp Pharm; 1984 Apr; 41(4):667-75. PubMed ID: 6720708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inadequate medical order writing. A source of confusion and increased costs.
    Larson EB; Scott DH; Kaplan HG
    West J Med; 1983 Jul; 139(1):50-4. PubMed ID: 6624083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacy-based antimicrobial-monitoring service.
    Berman JR; Zaran FK; Rybak MJ
    Am J Hosp Pharm; 1992 Jul; 49(7):1701-6. PubMed ID: 1621727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Panel discussion: hospital intravenous additive programs. I. An analysis of a hospital's I.V. additive service.
    Schwarz MA
    Bull Parenter Drug Assoc; 1969; 23(2):78-80. PubMed ID: 5776422
    [No Abstract]   [Full Text] [Related]  

  • 40. Irreversible renal failure after intraperitoneal cisplatin administration. A case report.
    Gouge SF; Tietjen DP; Moore J
    J Reprod Med; 1989 Nov; 34(11):931-3. PubMed ID: 2585396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.